nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC5—Zidovudine—acquired immunodeficiency syndrome	0.0747	0.102	CbGbCtD
Sildenafil—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0359	0.049	CbGbCtD
Sildenafil—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0277	0.0379	CbGbCtD
Sildenafil—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0196	0.0268	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0196	0.0268	CbGbCtD
Sildenafil—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0169	0.0231	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0169	0.0231	CbGbCtD
Sildenafil—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0164	0.0225	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0164	0.0225	CbGbCtD
Sildenafil—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0163	0.0222	CbGbCtD
Sildenafil—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0149	0.0203	CbGbCtD
Sildenafil—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0149	0.0203	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0149	0.0203	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0149	0.0203	CbGbCtD
Sildenafil—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0147	0.0201	CbGbCtD
Sildenafil—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0147	0.0201	CbGbCtD
Sildenafil—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0143	0.0196	CbGbCtD
Sildenafil—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.014	0.0191	CbGbCtD
Sildenafil—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0131	0.0179	CbGbCtD
Sildenafil—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0127	0.0174	CbGbCtD
Sildenafil—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0123	0.0168	CbGbCtD
Sildenafil—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0119	0.0162	CbGbCtD
Sildenafil—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0119	0.0162	CbGbCtD
Sildenafil—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0116	0.0159	CbGbCtD
Sildenafil—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0111	0.0152	CbGbCtD
Sildenafil—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0111	0.0152	CbGbCtD
Sildenafil—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0109	0.0149	CbGbCtD
Sildenafil—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0109	0.0149	CbGbCtD
Sildenafil—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0106	0.0145	CbGbCtD
Sildenafil—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0102	0.014	CbGbCtD
Sildenafil—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00997	0.0136	CbGbCtD
Sildenafil—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00997	0.0136	CbGbCtD
Sildenafil—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00994	0.0136	CbGbCtD
Sildenafil—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00986	0.0135	CbGbCtD
Sildenafil—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00986	0.0135	CbGbCtD
Sildenafil—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00902	0.0123	CbGbCtD
Sildenafil—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00902	0.0123	CbGbCtD
Sildenafil—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00899	0.0123	CbGbCtD
Sildenafil—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00899	0.0123	CbGbCtD
Sildenafil—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00862	0.0118	CbGbCtD
Sildenafil—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00852	0.0116	CbGbCtD
Sildenafil—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00827	0.0113	CbGbCtD
Sildenafil—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00779	0.0106	CbGbCtD
Sildenafil—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00756	0.0103	CbGbCtD
Sildenafil—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00748	0.0102	CbGbCtD
Sildenafil—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00748	0.0102	CbGbCtD
Sildenafil—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00717	0.00979	CbGbCtD
Sildenafil—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00684	0.00934	CbGbCtD
Sildenafil—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00684	0.00934	CbGbCtD
Sildenafil—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00675	0.00922	CbGbCtD
Sildenafil—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00634	0.00867	CbGbCtD
Sildenafil—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00634	0.00867	CbGbCtD
Sildenafil—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00574	0.00784	CbGbCtD
Sildenafil—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00574	0.00784	CbGbCtD
Sildenafil—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00495	0.00677	CbGbCtD
Sildenafil—PDE6C—retina—acquired immunodeficiency syndrome	0.00484	0.0809	CbGeAlD
Sildenafil—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00481	0.00657	CbGbCtD
Sildenafil—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00435	0.00594	CbGbCtD
Sildenafil—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00435	0.00594	CbGbCtD
Sildenafil—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00417	0.00569	CbGbCtD
Sildenafil—PDE6H—retina—acquired immunodeficiency syndrome	0.00285	0.0477	CbGeAlD
Sildenafil—PDE6G—retina—acquired immunodeficiency syndrome	0.00275	0.0459	CbGeAlD
Sildenafil—PDE5A—endothelium—acquired immunodeficiency syndrome	0.00223	0.0373	CbGeAlD
Sildenafil—PDE5A—blood plasma—acquired immunodeficiency syndrome	0.00198	0.0331	CbGeAlD
Sildenafil—PDE6G—blood—acquired immunodeficiency syndrome	0.00184	0.0307	CbGeAlD
Sildenafil—PDE6G—lung—acquired immunodeficiency syndrome	0.00161	0.0269	CbGeAlD
Sildenafil—PDE6H—nervous system—acquired immunodeficiency syndrome	0.00155	0.0259	CbGeAlD
Sildenafil—PDE6H—central nervous system—acquired immunodeficiency syndrome	0.00149	0.0249	CbGeAlD
Sildenafil—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.00126	0.021	CbGeAlD
Sildenafil—PDE6H—brain—acquired immunodeficiency syndrome	0.00118	0.0198	CbGeAlD
Sildenafil—PDE6G—lymph node—acquired immunodeficiency syndrome	0.0011	0.0184	CbGeAlD
Sildenafil—PDE5A—retina—acquired immunodeficiency syndrome	0.00109	0.0181	CbGeAlD
Sildenafil—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0175	CbGeAlD
Sildenafil—ABCC5—retina—acquired immunodeficiency syndrome	0.000993	0.0166	CbGeAlD
Sildenafil—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.000847	0.0142	CbGeAlD
Sildenafil—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000823	0.0138	CbGeAlD
Sildenafil—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00081	0.0135	CbGeAlD
Sildenafil—ADORA2A—blood—acquired immunodeficiency syndrome	0.000797	0.0133	CbGeAlD
Sildenafil—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.000768	0.0128	CbGeAlD
Sildenafil—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000768	0.0128	CbGeAlD
Sildenafil—PDE5A—digestive system—acquired immunodeficiency syndrome	0.000762	0.0127	CbGeAlD
Sildenafil—PDE5A—blood—acquired immunodeficiency syndrome	0.000726	0.0121	CbGeAlD
Sildenafil—PDE5A—vagina—acquired immunodeficiency syndrome	0.000673	0.0112	CbGeAlD
Sildenafil—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.000647	0.0108	CbGeAlD
Sildenafil—ABCC5—bone marrow—acquired immunodeficiency syndrome	0.000643	0.0107	CbGeAlD
Sildenafil—PDE5A—lung—acquired immunodeficiency syndrome	0.000637	0.0106	CbGeAlD
Sildenafil—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.000623	0.0104	CbGeAlD
Sildenafil—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000618	0.0103	CbGeAlD
Sildenafil—ABCC5—vagina—acquired immunodeficiency syndrome	0.000616	0.0103	CbGeAlD
Sildenafil—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000608	0.0102	CbGeAlD
Sildenafil—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.00059	0.00986	CbGeAlD
Sildenafil—PDE5A—nervous system—acquired immunodeficiency syndrome	0.000589	0.00985	CbGeAlD
Sildenafil—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000583	0.00974	CbGeAlD
Sildenafil—ABCC5—lung—acquired immunodeficiency syndrome	0.000582	0.00973	CbGeAlD
Sildenafil—PDE5A—central nervous system—acquired immunodeficiency syndrome	0.000568	0.00949	CbGeAlD
Sildenafil—ABCC10—blood—acquired immunodeficiency syndrome	0.000555	0.00928	CbGeAlD
Sildenafil—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000537	0.00897	CbGeAlD
Sildenafil—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.000535	0.00894	CbGeAlD
Sildenafil—ABCC10—vagina—acquired immunodeficiency syndrome	0.000514	0.0086	CbGeAlD
Sildenafil—ADORA2A—brain—acquired immunodeficiency syndrome	0.000495	0.00827	CbGeAlD
Sildenafil—ABCC10—lung—acquired immunodeficiency syndrome	0.000486	0.00813	CbGeAlD
Sildenafil—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000483	0.00808	CbGeAlD
Sildenafil—ABCC4—blood—acquired immunodeficiency syndrome	0.00046	0.00769	CbGeAlD
Sildenafil—PDE5A—brain—acquired immunodeficiency syndrome	0.000451	0.00753	CbGeAlD
Sildenafil—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000445	0.00744	CbGeAlD
Sildenafil—PDE5A—lymph node—acquired immunodeficiency syndrome	0.000435	0.00728	CbGeAlD
Sildenafil—ABCC5—brain—acquired immunodeficiency syndrome	0.000412	0.00689	CbGeAlD
Sildenafil—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000405	0.00677	CbGeAlD
Sildenafil—ABCC4—lung—acquired immunodeficiency syndrome	0.000404	0.00674	CbGeAlD
Sildenafil—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000402	0.00672	CbGeAlD
Sildenafil—ABCC5—lymph node—acquired immunodeficiency syndrome	0.000398	0.00666	CbGeAlD
Sildenafil—CYP2C19—blood—acquired immunodeficiency syndrome	0.000383	0.0064	CbGeAlD
Sildenafil—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000374	0.00625	CbGeAlD
Sildenafil—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.00036	0.00601	CbGeAlD
Sildenafil—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000355	0.00593	CbGeAlD
Sildenafil—ABCC10—brain—acquired immunodeficiency syndrome	0.000344	0.00576	CbGeAlD
Sildenafil—ABCC10—lymph node—acquired immunodeficiency syndrome	0.000333	0.00556	CbGeAlD
Sildenafil—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000324	0.00541	CbGeAlD
Sildenafil—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000317	0.00529	CbGeAlD
Sildenafil—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000312	0.00521	CbGeAlD
Sildenafil—CYP1A1—blood—acquired immunodeficiency syndrome	0.000308	0.00516	CbGeAlD
Sildenafil—CYP3A5—blood—acquired immunodeficiency syndrome	0.000302	0.00504	CbGeAlD
Sildenafil—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000299	0.005	CbGeAlD
Sildenafil—CYP2C9—blood—acquired immunodeficiency syndrome	0.000297	0.00496	CbGeAlD
Sildenafil—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000295	0.00494	CbGeAlD
Sildenafil—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000286	0.00478	CbGeAlD
Sildenafil—ABCC4—brain—acquired immunodeficiency syndrome	0.000286	0.00477	CbGeAlD
Sildenafil—CYP2E1—blood—acquired immunodeficiency syndrome	0.000281	0.0047	CbGeAlD
Sildenafil—CYP3A5—vagina—acquired immunodeficiency syndrome	0.00028	0.00467	CbGeAlD
Sildenafil—ABCC4—lymph node—acquired immunodeficiency syndrome	0.000276	0.00461	CbGeAlD
Sildenafil—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000271	0.00453	CbGeAlD
Sildenafil—CYP1A1—lung—acquired immunodeficiency syndrome	0.00027	0.00452	CbGeAlD
Sildenafil—CYP3A5—lung—acquired immunodeficiency syndrome	0.000264	0.00442	CbGeAlD
Sildenafil—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.00025	0.00419	CbGeAlD
Sildenafil—CYP2E1—lung—acquired immunodeficiency syndrome	0.000247	0.00412	CbGeAlD
Sildenafil—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000241	0.00403	CbGeAlD
Sildenafil—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000238	0.00397	CbGeAlD
Sildenafil—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000234	0.00391	CbGeAlD
Sildenafil—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000228	0.00382	CbGeAlD
Sildenafil—CYP3A4—blood—acquired immunodeficiency syndrome	0.000226	0.00378	CbGeAlD
Sildenafil—CYP2D6—blood—acquired immunodeficiency syndrome	0.000223	0.00372	CbGeAlD
Sildenafil—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.00022	0.00368	CbGeAlD
Sildenafil—CYP1A1—brain—acquired immunodeficiency syndrome	0.000191	0.0032	CbGeAlD
Sildenafil—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000185	0.00309	CbGeAlD
Sildenafil—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000184	0.00307	CbGeAlD
Sildenafil—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000181	0.00302	CbGeAlD
Sildenafil—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000177	0.00296	CbGeAlD
Sildenafil—CYP2E1—brain—acquired immunodeficiency syndrome	0.000175	0.00292	CbGeAlD
Sildenafil—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000174	0.00291	CbGeAlD
Sildenafil—CYP2D6—brain—acquired immunodeficiency syndrome	0.000138	0.00231	CbGeAlD
Sildenafil—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	9.3e-05	0.000446	CcSEcCtD
Sildenafil—Myalgia—Ritonavir—acquired immunodeficiency syndrome	9.29e-05	0.000446	CcSEcCtD
Sildenafil—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	9.29e-05	0.000446	CcSEcCtD
Sildenafil—Chest pain—Ritonavir—acquired immunodeficiency syndrome	9.29e-05	0.000446	CcSEcCtD
Sildenafil—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	9.26e-05	0.000445	CcSEcCtD
Sildenafil—Anaemia—Lamivudine—acquired immunodeficiency syndrome	9.26e-05	0.000445	CcSEcCtD
Sildenafil—Anxiety—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.000445	CcSEcCtD
Sildenafil—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	9.23e-05	0.000443	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.23e-05	0.000443	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.2e-05	0.000442	CcSEcCtD
Sildenafil—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.19e-05	0.000441	CcSEcCtD
Sildenafil—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.19e-05	0.000441	CcSEcCtD
Sildenafil—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.18e-05	0.000441	CcSEcCtD
Sildenafil—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.18e-05	0.000441	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.17e-05	0.00044	CcSEcCtD
Sildenafil—Cough—Saquinavir—acquired immunodeficiency syndrome	9.17e-05	0.00044	CcSEcCtD
Sildenafil—Pain—Indinavir—acquired immunodeficiency syndrome	9.11e-05	0.000437	CcSEcCtD
Sildenafil—Constipation—Indinavir—acquired immunodeficiency syndrome	9.11e-05	0.000437	CcSEcCtD
Sildenafil—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.11e-05	0.000437	CcSEcCtD
Sildenafil—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.1e-05	0.000437	CcSEcCtD
Sildenafil—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.1e-05	0.000437	CcSEcCtD
Sildenafil—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.09e-05	0.000436	CcSEcCtD
Sildenafil—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.07e-05	0.000435	CcSEcCtD
Sildenafil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.06e-05	0.000435	CcSEcCtD
Sildenafil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.06e-05	0.000435	CcSEcCtD
Sildenafil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.05e-05	0.000434	CcSEcCtD
Sildenafil—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.04e-05	0.000434	CcSEcCtD
Sildenafil—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.04e-05	0.000434	CcSEcCtD
Sildenafil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.02e-05	0.000433	CcSEcCtD
Sildenafil—Nausea—Didanosine—acquired immunodeficiency syndrome	9.02e-05	0.000433	CcSEcCtD
Sildenafil—Vertigo—Lamivudine—acquired immunodeficiency syndrome	9.01e-05	0.000432	CcSEcCtD
Sildenafil—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9e-05	0.000432	CcSEcCtD
Sildenafil—Syncope—Lamivudine—acquired immunodeficiency syndrome	8.99e-05	0.000431	CcSEcCtD
Sildenafil—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	8.98e-05	0.000431	CcSEcCtD
Sildenafil—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	8.97e-05	0.000431	CcSEcCtD
Sildenafil—Somnolence—Efavirenz—acquired immunodeficiency syndrome	8.95e-05	0.00043	CcSEcCtD
Sildenafil—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	8.95e-05	0.000429	CcSEcCtD
Sildenafil—Chest pain—Saquinavir—acquired immunodeficiency syndrome	8.95e-05	0.000429	CcSEcCtD
Sildenafil—Myalgia—Saquinavir—acquired immunodeficiency syndrome	8.95e-05	0.000429	CcSEcCtD
Sildenafil—Anxiety—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000428	CcSEcCtD
Sildenafil—Oedema—Ritonavir—acquired immunodeficiency syndrome	8.91e-05	0.000428	CcSEcCtD
Sildenafil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	8.89e-05	0.000427	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	8.88e-05	0.000426	CcSEcCtD
Sildenafil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	8.86e-05	0.000425	CcSEcCtD
Sildenafil—Discomfort—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.000424	CcSEcCtD
Sildenafil—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	8.81e-05	0.000423	CcSEcCtD
Sildenafil—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	8.78e-05	0.000422	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	8.78e-05	0.000421	CcSEcCtD
Sildenafil—Shock—Ritonavir—acquired immunodeficiency syndrome	8.77e-05	0.000421	CcSEcCtD
Sildenafil—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	8.75e-05	0.00042	CcSEcCtD
Sildenafil—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	8.75e-05	0.00042	CcSEcCtD
Sildenafil—Cough—Lamivudine—acquired immunodeficiency syndrome	8.75e-05	0.00042	CcSEcCtD
Sildenafil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	8.75e-05	0.00042	CcSEcCtD
Sildenafil—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	8.74e-05	0.000419	CcSEcCtD
Sildenafil—Dizziness—Stavudine—acquired immunodeficiency syndrome	8.72e-05	0.000418	CcSEcCtD
Sildenafil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	8.71e-05	0.000418	CcSEcCtD
Sildenafil—Insomnia—Delavirdine—acquired immunodeficiency syndrome	8.71e-05	0.000418	CcSEcCtD
Sildenafil—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.000417	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	8.69e-05	0.000417	CcSEcCtD
Sildenafil—Convulsion—Lamivudine—acquired immunodeficiency syndrome	8.68e-05	0.000417	CcSEcCtD
Sildenafil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	8.68e-05	0.000417	CcSEcCtD
Sildenafil—Fatigue—Efavirenz—acquired immunodeficiency syndrome	8.68e-05	0.000417	CcSEcCtD
Sildenafil—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	8.65e-05	0.000415	CcSEcCtD
Sildenafil—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	8.65e-05	0.000415	CcSEcCtD
Sildenafil—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.000413	CcSEcCtD
Sildenafil—Constipation—Efavirenz—acquired immunodeficiency syndrome	8.61e-05	0.000413	CcSEcCtD
Sildenafil—Pain—Efavirenz—acquired immunodeficiency syndrome	8.61e-05	0.000413	CcSEcCtD
Sildenafil—Rash—Nevirapine—acquired immunodeficiency syndrome	8.61e-05	0.000413	CcSEcCtD
Sildenafil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	8.6e-05	0.000413	CcSEcCtD
Sildenafil—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	8.59e-05	0.000412	CcSEcCtD
Sildenafil—Dizziness—Abacavir—acquired immunodeficiency syndrome	8.59e-05	0.000412	CcSEcCtD
Sildenafil—Oedema—Saquinavir—acquired immunodeficiency syndrome	8.58e-05	0.000412	CcSEcCtD
Sildenafil—Somnolence—Delavirdine—acquired immunodeficiency syndrome	8.56e-05	0.000411	CcSEcCtD
Sildenafil—Headache—Nevirapine—acquired immunodeficiency syndrome	8.55e-05	0.000411	CcSEcCtD
Sildenafil—Chest pain—Lamivudine—acquired immunodeficiency syndrome	8.53e-05	0.00041	CcSEcCtD
Sildenafil—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	8.53e-05	0.00041	CcSEcCtD
Sildenafil—Myalgia—Lamivudine—acquired immunodeficiency syndrome	8.53e-05	0.00041	CcSEcCtD
Sildenafil—Infection—Saquinavir—acquired immunodeficiency syndrome	8.52e-05	0.000409	CcSEcCtD
Sildenafil—Anxiety—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.000408	CcSEcCtD
Sildenafil—Anorexia—Ritonavir—acquired immunodeficiency syndrome	8.49e-05	0.000408	CcSEcCtD
Sildenafil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	8.48e-05	0.000407	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	8.47e-05	0.000407	CcSEcCtD
Sildenafil—Urticaria—Indinavir—acquired immunodeficiency syndrome	8.47e-05	0.000406	CcSEcCtD
Sildenafil—Shock—Saquinavir—acquired immunodeficiency syndrome	8.44e-05	0.000405	CcSEcCtD
Sildenafil—Discomfort—Lamivudine—acquired immunodeficiency syndrome	8.43e-05	0.000405	CcSEcCtD
Sildenafil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	8.42e-05	0.000404	CcSEcCtD
Sildenafil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.42e-05	0.000404	CcSEcCtD
Sildenafil—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	8.41e-05	0.000404	CcSEcCtD
Sildenafil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.41e-05	0.000404	CcSEcCtD
Sildenafil—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.38e-05	0.000402	CcSEcCtD
Sildenafil—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	8.38e-05	0.000402	CcSEcCtD
Sildenafil—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	8.35e-05	0.000401	CcSEcCtD
Sildenafil—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.34e-05	0.0004	CcSEcCtD
Sildenafil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.33e-05	0.0004	CcSEcCtD
Sildenafil—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	8.33e-05	0.0004	CcSEcCtD
Sildenafil—Hypotension—Ritonavir—acquired immunodeficiency syndrome	8.33e-05	0.0004	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.32e-05	0.000399	CcSEcCtD
Sildenafil—Rash—Stavudine—acquired immunodeficiency syndrome	8.31e-05	0.000399	CcSEcCtD
Sildenafil—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.31e-05	0.000399	CcSEcCtD
Sildenafil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.31e-05	0.000399	CcSEcCtD
Sildenafil—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.3e-05	0.000398	CcSEcCtD
Sildenafil—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	8.29e-05	0.000398	CcSEcCtD
Sildenafil—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.29e-05	0.000398	CcSEcCtD
Sildenafil—Headache—Stavudine—acquired immunodeficiency syndrome	8.26e-05	0.000396	CcSEcCtD
Sildenafil—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.26e-05	0.000396	CcSEcCtD
Sildenafil—Pain—Delavirdine—acquired immunodeficiency syndrome	8.24e-05	0.000395	CcSEcCtD
Sildenafil—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.24e-05	0.000395	CcSEcCtD
Sildenafil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.23e-05	0.000395	CcSEcCtD
Sildenafil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.22e-05	0.000395	CcSEcCtD
Sildenafil—Rash—Abacavir—acquired immunodeficiency syndrome	8.19e-05	0.000393	CcSEcCtD
Sildenafil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.18e-05	0.000393	CcSEcCtD
Sildenafil—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.18e-05	0.000393	CcSEcCtD
Sildenafil—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.17e-05	0.000392	CcSEcCtD
Sildenafil—Headache—Abacavir—acquired immunodeficiency syndrome	8.14e-05	0.000391	CcSEcCtD
Sildenafil—Infection—Lamivudine—acquired immunodeficiency syndrome	8.13e-05	0.00039	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.12e-05	0.00039	CcSEcCtD
Sildenafil—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.11e-05	0.000389	CcSEcCtD
Sildenafil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.11e-05	0.000389	CcSEcCtD
Sildenafil—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.06e-05	0.000387	CcSEcCtD
Sildenafil—Shock—Lamivudine—acquired immunodeficiency syndrome	8.05e-05	0.000386	CcSEcCtD
Sildenafil—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.02e-05	0.000385	CcSEcCtD
Sildenafil—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.01e-05	0.000385	CcSEcCtD
Sildenafil—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8e-05	0.000384	CcSEcCtD
Sildenafil—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8e-05	0.000384	CcSEcCtD
Sildenafil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	7.96e-05	0.000382	CcSEcCtD
Sildenafil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	7.96e-05	0.000382	CcSEcCtD
Sildenafil—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	7.95e-05	0.000381	CcSEcCtD
Sildenafil—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	7.94e-05	0.000381	CcSEcCtD
Sildenafil—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	7.94e-05	0.000381	CcSEcCtD
Sildenafil—Somnolence—Ritonavir—acquired immunodeficiency syndrome	7.92e-05	0.00038	CcSEcCtD
Sildenafil—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	7.91e-05	0.00038	CcSEcCtD
Sildenafil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	7.88e-05	0.000378	CcSEcCtD
Sildenafil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	7.86e-05	0.000377	CcSEcCtD
Sildenafil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	7.85e-05	0.000377	CcSEcCtD
Sildenafil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	7.84e-05	0.000376	CcSEcCtD
Sildenafil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	7.84e-05	0.000376	CcSEcCtD
Sildenafil—Nausea—Stavudine—acquired immunodeficiency syndrome	7.83e-05	0.000376	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	7.81e-05	0.000375	CcSEcCtD
Sildenafil—Anorexia—Lamivudine—acquired immunodeficiency syndrome	7.8e-05	0.000374	CcSEcCtD
Sildenafil—Insomnia—Saquinavir—acquired immunodeficiency syndrome	7.76e-05	0.000372	CcSEcCtD
Sildenafil—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.000372	CcSEcCtD
Sildenafil—Nausea—Abacavir—acquired immunodeficiency syndrome	7.71e-05	0.00037	CcSEcCtD
Sildenafil—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	7.7e-05	0.00037	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	7.69e-05	0.000369	CcSEcCtD
Sildenafil—Fatigue—Ritonavir—acquired immunodeficiency syndrome	7.68e-05	0.000369	CcSEcCtD
Sildenafil—Urticaria—Delavirdine—acquired immunodeficiency syndrome	7.65e-05	0.000367	CcSEcCtD
Sildenafil—Asthenia—Indinavir—acquired immunodeficiency syndrome	7.65e-05	0.000367	CcSEcCtD
Sildenafil—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	7.65e-05	0.000367	CcSEcCtD
Sildenafil—Hypotension—Lamivudine—acquired immunodeficiency syndrome	7.64e-05	0.000367	CcSEcCtD
Sildenafil—Somnolence—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.000366	CcSEcCtD
Sildenafil—Constipation—Ritonavir—acquired immunodeficiency syndrome	7.62e-05	0.000366	CcSEcCtD
Sildenafil—Pain—Ritonavir—acquired immunodeficiency syndrome	7.62e-05	0.000366	CcSEcCtD
Sildenafil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	7.62e-05	0.000366	CcSEcCtD
Sildenafil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	7.62e-05	0.000366	CcSEcCtD
Sildenafil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	7.58e-05	0.000364	CcSEcCtD
Sildenafil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	7.55e-05	0.000362	CcSEcCtD
Sildenafil—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.54e-05	0.000362	CcSEcCtD
Sildenafil—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.000358	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.45e-05	0.000358	CcSEcCtD
Sildenafil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	7.42e-05	0.000356	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.4e-05	0.000355	CcSEcCtD
Sildenafil—Insomnia—Lamivudine—acquired immunodeficiency syndrome	7.4e-05	0.000355	CcSEcCtD
Sildenafil—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.39e-05	0.000355	CcSEcCtD
Sildenafil—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000353	CcSEcCtD
Sildenafil—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.34e-05	0.000352	CcSEcCtD
Sildenafil—Pain—Saquinavir—acquired immunodeficiency syndrome	7.33e-05	0.000352	CcSEcCtD
Sildenafil—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.33e-05	0.000352	CcSEcCtD
Sildenafil—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.29e-05	0.00035	CcSEcCtD
Sildenafil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.29e-05	0.00035	CcSEcCtD
Sildenafil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.29e-05	0.00035	CcSEcCtD
Sildenafil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.29e-05	0.00035	CcSEcCtD
Sildenafil—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000349	CcSEcCtD
Sildenafil—Rash—Zidovudine—acquired immunodeficiency syndrome	7.23e-05	0.000347	CcSEcCtD
Sildenafil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.22e-05	0.000347	CcSEcCtD
Sildenafil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.22e-05	0.000346	CcSEcCtD
Sildenafil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.2e-05	0.000346	CcSEcCtD
Sildenafil—Headache—Zidovudine—acquired immunodeficiency syndrome	7.18e-05	0.000345	CcSEcCtD
Sildenafil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.12e-05	0.000342	CcSEcCtD
Sildenafil—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000341	CcSEcCtD
Sildenafil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.000341	CcSEcCtD
Sildenafil—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.08e-05	0.00034	CcSEcCtD
Sildenafil—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.07e-05	0.000339	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.06e-05	0.000339	CcSEcCtD
Sildenafil—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000339	CcSEcCtD
Sildenafil—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.05e-05	0.000338	CcSEcCtD
Sildenafil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.04e-05	0.000338	CcSEcCtD
Sildenafil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.04e-05	0.000338	CcSEcCtD
Sildenafil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.01e-05	0.000337	CcSEcCtD
Sildenafil—Pain—Lamivudine—acquired immunodeficiency syndrome	7e-05	0.000336	CcSEcCtD
Sildenafil—Constipation—Lamivudine—acquired immunodeficiency syndrome	7e-05	0.000336	CcSEcCtD
Sildenafil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	6.91e-05	0.000332	CcSEcCtD
Sildenafil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	6.89e-05	0.000331	CcSEcCtD
Sildenafil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.82e-05	0.000327	CcSEcCtD
Sildenafil—Urticaria—Saquinavir—acquired immunodeficiency syndrome	6.81e-05	0.000327	CcSEcCtD
Sildenafil—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.81e-05	0.000327	CcSEcCtD
Sildenafil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	6.78e-05	0.000325	CcSEcCtD
Sildenafil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	6.78e-05	0.000325	CcSEcCtD
Sildenafil—Vomiting—Indinavir—acquired immunodeficiency syndrome	6.78e-05	0.000325	CcSEcCtD
Sildenafil—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	6.74e-05	0.000324	CcSEcCtD
Sildenafil—Rash—Indinavir—acquired immunodeficiency syndrome	6.72e-05	0.000323	CcSEcCtD
Sildenafil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	6.71e-05	0.000322	CcSEcCtD
Sildenafil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	6.69e-05	0.000321	CcSEcCtD
Sildenafil—Headache—Indinavir—acquired immunodeficiency syndrome	6.68e-05	0.00032	CcSEcCtD
Sildenafil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	6.66e-05	0.00032	CcSEcCtD
Sildenafil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.59e-05	0.000316	CcSEcCtD
Sildenafil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.56e-05	0.000315	CcSEcCtD
Sildenafil—Urticaria—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.000312	CcSEcCtD
Sildenafil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.47e-05	0.00031	CcSEcCtD
Sildenafil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.47e-05	0.00031	CcSEcCtD
Sildenafil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.4e-05	0.000307	CcSEcCtD
Sildenafil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.39e-05	0.000307	CcSEcCtD
Sildenafil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.37e-05	0.000306	CcSEcCtD
Sildenafil—Rash—Efavirenz—acquired immunodeficiency syndrome	6.35e-05	0.000305	CcSEcCtD
Sildenafil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.34e-05	0.000304	CcSEcCtD
Sildenafil—Nausea—Indinavir—acquired immunodeficiency syndrome	6.33e-05	0.000304	CcSEcCtD
Sildenafil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000303	CcSEcCtD
Sildenafil—Headache—Efavirenz—acquired immunodeficiency syndrome	6.31e-05	0.000303	CcSEcCtD
Sildenafil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.3e-05	0.000303	CcSEcCtD
Sildenafil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.15e-05	0.000295	CcSEcCtD
Sildenafil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.000294	CcSEcCtD
Sildenafil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.000293	CcSEcCtD
Sildenafil—Rash—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000292	CcSEcCtD
Sildenafil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000291	CcSEcCtD
Sildenafil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.07e-05	0.000291	CcSEcCtD
Sildenafil—Headache—Delavirdine—acquired immunodeficiency syndrome	6.04e-05	0.00029	CcSEcCtD
Sildenafil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000289	CcSEcCtD
Sildenafil—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.98e-05	0.000287	CcSEcCtD
Sildenafil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.89e-05	0.000283	CcSEcCtD
Sildenafil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.87e-05	0.000282	CcSEcCtD
Sildenafil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000282	CcSEcCtD
Sildenafil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.79e-05	0.000278	CcSEcCtD
Sildenafil—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.72e-05	0.000275	CcSEcCtD
Sildenafil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.67e-05	0.000272	CcSEcCtD
Sildenafil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.000272	CcSEcCtD
Sildenafil—Rash—Ritonavir—acquired immunodeficiency syndrome	5.62e-05	0.00027	CcSEcCtD
Sildenafil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.61e-05	0.000269	CcSEcCtD
Sildenafil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000269	CcSEcCtD
Sildenafil—Headache—Ritonavir—acquired immunodeficiency syndrome	5.58e-05	0.000268	CcSEcCtD
Sildenafil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.45e-05	0.000262	CcSEcCtD
Sildenafil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.41e-05	0.00026	CcSEcCtD
Sildenafil—Rash—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.00026	CcSEcCtD
Sildenafil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.4e-05	0.000259	CcSEcCtD
Sildenafil—Headache—Saquinavir—acquired immunodeficiency syndrome	5.37e-05	0.000258	CcSEcCtD
Sildenafil—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.29e-05	0.000254	CcSEcCtD
Sildenafil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.2e-05	0.00025	CcSEcCtD
Sildenafil—Rash—Lamivudine—acquired immunodeficiency syndrome	5.16e-05	0.000248	CcSEcCtD
Sildenafil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.15e-05	0.000247	CcSEcCtD
Sildenafil—Headache—Lamivudine—acquired immunodeficiency syndrome	5.12e-05	0.000246	CcSEcCtD
Sildenafil—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.09e-05	0.000244	CcSEcCtD
Sildenafil—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.86e-05	0.000233	CcSEcCtD
